Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation
- 31 May 2012
- journal article
- Published by Elsevier BV in Matrix Biology
- Vol. 31 (4), 234-245
- https://doi.org/10.1016/j.matbio.2012.02.006
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health (19791047, 21791418, 22300223)
- National Institute of Dental and Craniofacial Research
This publication has 66 references indexed in Scilit:
- Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the α2β1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)Online Journal of Public Health Informatics, 2011
- Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber compositionMatrix Biology, 2010
- Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axisMatrix Biology, 2009
- Overexpression of Vascular Endothelial Growth Factor 189 in Breast Cancer Cells Leads to Delayed Tumor Uptake with Dilated Intratumoral VesselsThe American Journal of Pathology, 2008
- Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptorsMatrix Biology, 2007
- Chondroitin Sulfate Perlecan Enhances Collagen Fibril Formation: IMPLICATIONS FOR PERLECAN CHONDRODYSPLASIASJournal of Biological Chemistry, 2006
- Modulation of FGF-2 binding to chondrocytes from the developing growth plate by perlecanMatrix Biology, 2006
- Membrane associated proteases and their inhibitors in tumour angiogenesisJournal of Clinical Pathology, 2004
- Developmental regulation of the growth plateNature, 2003
- Perlecan in human bone marrow: A growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cellsMatrix Biology, 1995